AU2002304785A1 - Use of cysteine protease-inhibitors for treating illnesses - Google Patents

Use of cysteine protease-inhibitors for treating illnesses

Info

Publication number
AU2002304785A1
AU2002304785A1 AU2002304785A AU2002304785A AU2002304785A1 AU 2002304785 A1 AU2002304785 A1 AU 2002304785A1 AU 2002304785 A AU2002304785 A AU 2002304785A AU 2002304785 A AU2002304785 A AU 2002304785A AU 2002304785 A1 AU2002304785 A1 AU 2002304785A1
Authority
AU
Australia
Prior art keywords
inhibitors
cysteine protease
treating illnesses
illnesses
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002304785A
Other languages
English (en)
Inventor
Wilfried Lubisch
Achim Moeller
Heinz Neuhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Publication of AU2002304785A1 publication Critical patent/AU2002304785A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002304785A 2001-03-26 2002-03-26 Use of cysteine protease-inhibitors for treating illnesses Abandoned AU2002304785A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10114762.7 2001-03-26
DE10114762A DE10114762A1 (de) 2001-03-26 2001-03-26 Verwendung von Cysteinprotease-Inhibitoren
PCT/EP2002/003399 WO2003080182A1 (de) 2001-03-26 2002-03-26 Verwendung von cysteinprotease-inhibitoren zur behandlung von erkrankungen

Publications (1)

Publication Number Publication Date
AU2002304785A1 true AU2002304785A1 (en) 2003-10-08

Family

ID=7679056

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002304785A Abandoned AU2002304785A1 (en) 2001-03-26 2002-03-26 Use of cysteine protease-inhibitors for treating illnesses

Country Status (3)

Country Link
AU (1) AU2002304785A1 (de)
DE (1) DE10114762A1 (de)
WO (1) WO2003080182A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA100501C2 (uk) 2006-12-29 2013-01-10 Ебботт Гмбх Унд Ко. Кг Карбоксамідні сполуки і їх застосування як інгібіторів кальпаїнів
TWI453019B (zh) 2007-12-28 2014-09-21 Abbvie Deutschland 甲醯胺化合物
US20110117106A1 (en) * 2008-03-06 2011-05-19 Alice Prince Uses of calpain inhibitors to inhibit inflammation
TWI519530B (zh) 2009-02-20 2016-02-01 艾伯維德國有限及兩合公司 羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
US9051304B2 (en) 2009-12-22 2015-06-09 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
US8598211B2 (en) 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
MX2013006419A (es) 2010-12-09 2013-12-16 Abbvie Inc Compuestos carboxamida y su uso como inhibidores de calpaina v.
CN104364247A (zh) 2012-04-03 2015-02-18 艾伯维德国有限责任两合公司 甲酰胺化合物及它们作为钙蛋白酶抑制剂v的用途
EP3426674A4 (de) 2016-03-09 2019-08-14 Blade Therapeutics, Inc. Cyclische keto-amid-verbindungen als calpain-modulatoren sowie verfahren zur herstellung und verwendung davon
US11292801B2 (en) 2016-07-05 2022-04-05 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
US10934261B2 (en) 2016-09-28 2021-03-02 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013549A1 (en) * 1991-02-07 1992-08-20 Research Corporation Technologies, Inc. Inhibition of cell proliferation by hydrophobic peptides
US5916887A (en) * 1996-09-23 1999-06-29 National Research Council Of Canada 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
DE19642591A1 (de) * 1996-10-15 1998-04-16 Basf Ag Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
DE19648793A1 (de) * 1996-11-26 1998-05-28 Basf Ag Neue Benzamide und deren Anwendung
EP1080083A1 (de) * 1998-04-20 2001-03-07 Basf Aktiengesellschaft Neue heterocyclisch substituierte amide mit cystein-protease hemmender wirkung
BR9909774A (pt) * 1998-04-20 2000-12-19 Basf Ag Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
DE19818614A1 (de) * 1998-04-20 1999-10-21 Basf Ag Neue substituierte Amide, deren Herstellung und Anwendung
HUP0101599A3 (en) * 1998-04-20 2002-12-28 Basf Ag Heterocyclically substituted amides, process for producing them, use of them and pharmaceutical compositions containing them
DE19817461A1 (de) * 1998-04-20 1999-10-21 Basf Ag Neue substituierte Benzamide, deren Herstellung und Anwendung
DE19817459A1 (de) * 1998-04-20 1999-10-21 Basf Ag Neue heterozyklische substituierte Amide, Herstellung und Anwendung
BR9910701A (pt) * 1998-05-25 2001-01-30 Basf Ag Amida, uso de amidas, e, preparação farmacêutica

Also Published As

Publication number Publication date
WO2003080182A1 (de) 2003-10-02
DE10114762A1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
AU2002250331A1 (en) 7-pyrollyl tetracycline compounds and methods of use thereof
AU2002255752A1 (en) 9-aminoacyl tetracycline compounds and methods of use thereof
AU2002363005A1 (en) Derivatives of uk-2a
AU2002359687A1 (en) Multiple laser treatment
AU2002257936A1 (en) Methods of well treatment
AU2002314466A1 (en) Withasol and methods of use
AU2002304785A1 (en) Use of cysteine protease-inhibitors for treating illnesses
AU2002330095A1 (en) Flavonoids for treatment of diabetes
AU2002321349A1 (en) Method for modification of starch, starch and its use
AU2002320525A1 (en) Antisense modulation of glioma-associated oncogene-2 expression
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2002359694A1 (en) Compounds and methods
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002304626A1 (en) Sterilization of surfaces
AU2002303712A1 (en) Novel telomerase inhibitors and uses therefor
EP1578723A3 (de) Verfahren zur herstellung von oxazolidinonen und verfahren zu deren verwendung
AU2002367959A1 (en) Process for the preparation of oxazolidinones and method of use thereof
AU2002337843A1 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
AU2002350362A1 (en) Use of an anti-microtubule agent for the treatment of uveitis
AU2002305868A1 (en) Inhibitors of reggamma
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2002244086A1 (en) Antisense modulation of recql4 expression
AU2002315554A1 (en) Antisense modulation of glioma-associated oncogene-3 expression
AU2002257572A1 (en) Use of carnitine for increasing testosteron
AU2002311913A1 (en) Method of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase